Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA DR. REDDYS LAB DISHMAN PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 30.0 20.7 144.7% View Chart
P/BV x 3.3 3.9 85.4% View Chart
Dividend Yield % 0.7 0.7 99.3%  

Financials

 DISHMAN PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
DR. REDDYS LAB
Mar-22
DISHMAN PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3745,614 6.7%   
Low Rs1293,655 3.5%   
Sales per share (Unadj.) Rs197.01,294.6 15.2%  
Earnings per share (Unadj.) Rs21.2126.9 16.7%  
Cash flow per share (Unadj.) Rs34.7196.9 17.6%  
Dividends per share (Unadj.) Rs2.0030.00 6.7%  
Avg Dividend yield %0.80.6 122.8%  
Book value per share (Unadj.) Rs179.91,145.8 15.7%  
Shares outstanding (eoy) m80.70166.43 48.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.6 35.7%   
Avg P/E ratio x11.936.5 32.5%  
P/CF ratio (eoy) x7.323.5 30.8%  
Price / Book Value ratio x1.44.0 34.6%  
Dividend payout %9.423.6 39.9%   
Avg Mkt Cap Rs m20,307771,272 2.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35538,858 13.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898215,452 7.4%  
Other income Rs m2654,847 5.5%   
Total revenues Rs m16,163220,299 7.3%   
Gross profit Rs m4,10337,674 10.9%  
Depreciation Rs m1,09111,652 9.4%   
Interest Rs m944958 98.6%   
Profit before tax Rs m2,33429,911 7.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6248,789 7.1%   
Profit after tax Rs m1,71021,122 8.1%  
Gross profit margin %25.817.5 147.6%  
Effective tax rate %26.729.4 90.9%   
Net profit margin %10.89.8 109.7%  
BALANCE SHEET DATA
Current assets Rs m11,018177,880 6.2%   
Current liabilities Rs m9,51797,658 9.7%   
Net working cap to sales %9.437.2 25.4%  
Current ratio x1.21.8 63.6%  
Inventory Days Days5756 102.3%  
Debtors Days Days3113 3.1%  
Net fixed assets Rs m18,787106,819 17.6%   
Share capital Rs m161832 19.4%   
"Free" reserves Rs m14,354189,859 7.6%   
Net worth Rs m14,516190,691 7.6%   
Long term debt Rs m4,1895,746 72.9%   
Total assets Rs m29,805284,699 10.5%  
Interest coverage x3.532.2 10.8%   
Debt to equity ratio x0.30 957.8%  
Sales to assets ratio x0.50.8 70.5%   
Return on assets %8.97.8 114.8%  
Return on equity %11.811.1 106.4%  
Return on capital %17.515.7 111.5%  
Exports to sales %24.947.1 52.8%   
Imports to sales %3.718.8 19.9%   
Exports (fob) Rs m3,956101,544 3.9%   
Imports (cif) Rs m59440,401 1.5%   
Fx inflow Rs m4,952101,544 4.9%   
Fx outflow Rs m69740,401 1.7%   
Net fx Rs m4,25561,143 7.0%   
CASH FLOW
From Operations Rs m2,78628,108 9.9%  
From Investments Rs m-1,529-26,387 5.8%  
From Financial Activity Rs m-941-2,422 38.9%  
Net Cashflow Rs m31732 989.1%  

Share Holding

Indian Promoters % 61.4 26.7 230.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 50.7 45.3%  
FIIs % 12.0 27.3 43.9%  
ADR/GDR % 0.0 10.5 -  
Free float % 38.6 62.8 61.5%  
Shareholders   52,291 246,788 21.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Dr. Reddys Share Price Performance

Period Dishman Pharma Dr. Reddys S&P BSE HEALTHCARE
1-Day 2.87% 1.00% 1.20%
1-Month -2.45% 3.54% -3.18%
1-Year 96.38% 3.84% -7.59%
3-Year CAGR 89.34% 12.50% 16.43%
5-Year CAGR 38.20% 15.54% 9.40%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.